Evidence map›Paper›PMID 28934926›Full record

ArticleMedicinal chemistry (Shariqah (United Arab Emirates))2017

IRS-1 pY612 and Akt-1/PKB pT308 Phosphorylation and Antiinflammatory Effect of Diindolylmethane in Adipocytes Cocultured with Macrophages.

Alfonso Lopez-Vazquez, Jesus J Garcia-Banuelos, Angelica S Gonzalez-Garibay, Pedro E Urzua-Lozano, Susana Del Toro-Arreola, Miriam R Bueno-Topete, Sergio Sanchez-Enriquez, Jose F Munoz-Valle, Luis F Jave-Suarez, Juan Armendariz-Borunda and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Medicinal chemistry (Shariqah (United Arab Emirates)), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Alfonso Lopez-VazquezInstituto de Investigacion en Enfermedades Cronico Degenerativas, Departamento de Biologia Molecular y Genomica, Universidad de Guadalajara, Guadalajara, Jalisco. Mexico.
Jesus J Garcia-BanuelosInstituto de Biologia Molecular en Medicina y Terapia Genica, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, puerta 7, 3er. piso, Calle Sierra Mojada # 950, Col. Independencia, Guadalajara, Jalisco, C.P. 44340. Mexico.
Angelica S Gonzalez-GaribayInstituto de Investigacion en Enfermedades Cronico Degenerativas, Departamento de Biologia Molecular y Genomica, Universidad de Guadalajara, Guadalajara, Jalisco. Mexico.
Pedro E Urzua-LozanoInstituto de Investigacion en Enfermedades Cronico Degenerativas, Departamento de Biologia Molecular y Genomica, Universidad de Guadalajara, Guadalajara, Jalisco. Mexico.
Susana Del Toro-ArreolaInstituto de Investigacion en Enfermedades Cronico Degenerativas, Departamento de Biologia Molecular y Genomica, Universidad de Guadalajara, Guadalajara, Jalisco. Mexico.
Miriam R Bueno-TopeteInstituto de Investigacion en Enfermedades Cronico Degenerativas, Departamento de Biologia Molecular y Genomica, Universidad de Guadalajara, Guadalajara, Jalisco. Mexico.
Sergio Sanchez-EnriquezLaboratorio de Bioquimica, Departamento de Biologia Molecular y Genomica, Universidad de Guadalajara, Guadalajara, Jalisco. Mexico.
Jose F Munoz-ValleInstituto de Investigacion en Ciencias Biomedicas, Departamento de Biologia Molecular y Genomica, Universidad de Guadalajara, Guadalajara, Jalisco. Mexico.
Luis F Jave-SuarezCentro de Investigacion Biomedica de Occidente, Instituto Mexicano del Seguro Social, Guadalajara, Jalisco. Mexico.
Juan Armendariz-BorundaInstituto de Biologia Molecular en Medicina y Terapia Genica, Departamento de Biologia Molecular y Genomica, Universidad de Guadalajara, Guadalajara, Jalisco. Mexico.
Blanca E Bastidas-RamirezInstituto de Investigacion en Enfermedades Cronico Degenerativas, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, puerta 7, 2do. piso., Calle Sierra Mojada # 950, Col. Independencia, Guadalajara, Jalisco, C.P. 44340. Mexico.
Universidad de Guadalajara · MXMexican Social Security Institute · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background3,3'-Diindolylmethane (DIM) is a condensation product of indole-3-carbinol, a glucosinolate naturally occurring in Brassica genus vegetables. The antiinflammatory properties of DIM through the inhibition of NF-κB, as well as its ameliorating effects on glucose tolerance and hyperglicemic states, have been described. A subclinical proinflammatory profile resultant from the interaction of adipocytes and macrophages has been reported in obesity, affecting the insulin signaling pathway, contributing to insulin resistance.

objectiveThe aim of this study was to evaluate the effect of DIM on proinflammatory cytokines and phosphorylation of IRS-1 pY612 and Akt-1/PKB pT308 in an obesity-induced inflammation model.

methodsDifferentiated 3T3-L1 adipocytes were co-cultured with RAW 264.7 macrophages and exposed to 20 µM, 40 µM and 60 µM DIM for 24 h followed by 100 nM insulin for 20 min. MCP-1, IL-6 and TNFα were quantified in the supernatant through individual ELISAs. Adipocyte lysates were used to determine the relative expression of the proinflammatory mediators by qPCR, and the phosphorylation of IRS-1 pY612 and Akt-1/PKB pT308 proteins by western blot analysis.

resultsDIM significantly (p<0.05) reduced the production and mRNA expression of MCP-1, IL-6, and TNFα in a DIM concentration dependent manner, concomitantly increasing the abundance of IRS-1 pY612 and Akt-1/PKB pT308.

conclusionOur results suggest that DIM influences the insulin transduction pathway by exerting an antiinflammatory effect. The potential therapeutic benefits of DIM in the treatment of glucose metabolic disorders deserve further studies.

Indexed as

3T3-L1 CellsAdipocytesAnimalsAnti-Inflammatory Agents, Non-SteroidalCell DifferentiationCells, CulturedCoculture TechniquesDose-Response Relationship, DrugIndolesInsulin Receptor Substrate ProteinsMacrophagesMiceMolecular StructurePhosphorylationProto-Oncogene Proteins c-aktRAW 264.7 Cells3,3'-diindolylmethaneAkt1 protein, mouseAnti-Inflammatory Agents, Non-SteroidalIndolesInsulin Receptor Substrate ProteinsIrs1 protein, mouseProto-Oncogene Proteins c-aktDiabetes mellitus type 2glucoseinflammationinsulin resistanceinsulin signaling pathwayobesityphytochemicals

Identifiers

PMID28934926
PMCPMC5744426
OpenAlexW2757134356

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.